FY2025 R&D Tax Incentive Loan Funding
Filed with ASX · · 2 pages · English
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- NATA Accreditation Awarded for Genetype Laboratory
- ColoSTAT Beta kit verification and validation update
- Breast Cancer Risk Study University of Melbourne
- Quarterly Activities Report and Appendix 4C 31 March 2025
- EGM - Investor Presentation
Later from Rhythm Biosciences
- Jun 25 Quarterly Activities Report and Appendix 4C
- ColoSTAT Kits Deliver Breakthrough Results
- Response to ASX Price Query
- Placement Issue Investor Presentation
- Share Placement to Raise Up To $3.75 million
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences